3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
60
Lung Neoplasms
38
Melanoma
22
Ovarian Neoplasms
20
Breast Neoplasms
18
Mesothelioma, Malignant
13
Colorectal Neoplasms
13
Pancreatic Neoplasms
12
Neoplasm Metastasis
12
Small Cell Lung Carcinoma
11
Triple Negative Breast Neoplasms
10
Carcinoma, Renal Cell
10
Neoplasms
9
Mesothelioma
9
Stomach Neoplasms
8
Sarcoma
8
Thymoma
7
Carcinoma, Hepatocellular
7
Squamous Cell Carcinoma of Head and Neck
6
Carcinoma, Merkel Cell
6
Esophageal Neoplasms
5
Carcinoma, Transitional Cell
5
Adenocarcinoma of Lung
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Sarcoma, Synovial
4
Multiple Myeloma
4
Head and Neck Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Interventions
Specimen Handling
2
sargramostim
1
rucaparib
1
pembrolizumab
1
belinostat
1
X-Rays
1
Tissue Banks
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Cyclophosphamide
×
Thoracic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled